{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:26:13Z","timestamp":1791473173383,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81472383, 81772753, 81972419"],"award-info":[{"award-number":["81472383, 81772753, 81972419"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>For patients with prostate cancer (PCa), pelvic lymph node (LN) metastasis remains a major poor prognostic factor associated with cancer-specific mortality. VEGF-C is a major lymphangiogenic ligand that plays a vital role in LN metastasis in PCa. However, in some PCa caseswith LN metastasis,VEGF-C is not upregulated, indicating that some VEGF-C-independent mechanisms are essential for lymphangiogenesis.Herein, we confirmed that extracellular vesicles (EVs) derived from PCa cells could promote LN metastasis in PCa independent of VEGF-C. We identified an EV circular RNA, circPDLIM5, that could promote lymphangiogenesis and lymphatic metastasis in both PCa cell lines and mouse models. Mechanistically, the packaging of circPDLIM5 into EVs was regulated by heterogeneous nuclear ribonucleoprotein A2B1. Subsequently, EVs were transmitted to human lymphatic endothelial cells, and EVs carrying circPDLIM5 could then directly interact with the transcription factor Yin Yang 1 to enhance the expression of Prospero homeobox 1, which is crucial for the formation, differentiation, and maturation of lymphatic vessels. Our findingshighlight the importance of a molecular mechanism mediated by EVs carrying circPDLIM5that is involved in lymphangiogenesis and LN metastasis in PCa; as a result, EVscarrying circPDLIM5 may be an attractive therapeutic target for LN-metastatic PCa.<\/jats:p>","DOI":"10.1186\/s13046-025-03443-2","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T08:54:25Z","timestamp":1751532865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Extracellular vesicle-mediated transmission of circPDLIM5 promotes lymphatic metastasis in prostate cancer"],"prefix":"10.1186","volume":"44","author":[{"given":"Tao","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao-Lin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liao-Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"3443_CR1","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1056\/NEJMra1701695","volume":"378","author":"O Sartor","year":"2018","unstructured":"Sartor O, de Bono JS. Metastatic prostate cancer. N Engl J Med. 2018;378:645\u201357.","journal-title":"N Engl J Med"},{"key":"3443_CR2","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.eururo.2018.05.034","volume":"74","author":"W Wilczak","year":"2018","unstructured":"Wilczak W, Wittmer C, Clauditz T, Minner S, Steurer S, B\u00fcscheck F, Krech T, Lennartz M, Harms L, Leleu D, et al. Marked prognostic impact of minimal lymphatic tumor spread in prostate cancer. Eur Urol. 2018;74:376\u201386.","journal-title":"Eur Urol"},{"key":"3443_CR3","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.cmet.2021.08.006","volume":"33","author":"R Isaac","year":"2021","unstructured":"Isaac R, Reis FCG, Ying W, Olefsky JM. Exosomes as mediators of intercellular crosstalk in metabolism. Cell Metab. 2021;33:1744\u201362.","journal-title":"Cell Metab"},{"key":"3443_CR4","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977.","journal-title":"Science"},{"key":"3443_CR5","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","volume":"30","author":"A Becker","year":"2016","unstructured":"Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell. 2016;30:836\u201348.","journal-title":"Cancer Cell"},{"key":"3443_CR6","doi-asserted-by":"publisher","first-page":"15016","DOI":"10.1038\/ncomms15016","volume":"8","author":"H Zhang","year":"2017","unstructured":"Zhang H, Deng T, Liu R, Bai M, Zhou L, Wang X, Li S, Wang X, Yang H, Li J, et al. Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis. Nat Commun. 2017;8:15016.","journal-title":"Nat Commun"},{"key":"3443_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13045-020-00991-2","volume":"13","author":"S Zhao","year":"2020","unstructured":"Zhao S, Mi Y, Guan B, Zheng B, Wei P, Gu Y, Zhang Z, Cai S, Xu Y, Li X, et al. Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer. J Hematol Oncol. 2020;13:156.","journal-title":"J Hematol Oncol"},{"key":"3443_CR8","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/s43018-021-00272-y","volume":"2","author":"S Garc\u00eda-Silva","year":"2021","unstructured":"Garc\u00eda-Silva S, Benito-Mart\u00edn A, Nogu\u00e9s L, Hern\u00e1ndez-Barranco A, Mazariegos MS, Santos V, Hergueta-Redondo M, Xim\u00e9nez-Emb\u00fan P, Kataru RP, Lopez AA, et al. Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism. Nat Cancer. 2021;2:1387\u2013405.","journal-title":"Nat Cancer"},{"key":"3443_CR9","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41388-018-0511-x","volume":"38","author":"CF Zhou","year":"2019","unstructured":"Zhou CF, Ma J, Huang L, Yi HY, Zhang YM, Wu XG, Yan RM, Liang L, Zhong M, Yu YH, et al. Cervical squamous cell carcinoma-secreted exosomal miR-221\u20133p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1. Oncogene. 2019;38:1256\u201368.","journal-title":"Oncogene"},{"key":"3443_CR10","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1002\/ijc.32196","volume":"145","author":"B Sun","year":"2019","unstructured":"Sun B, Zhou Y, Fang Y, Li Z, Gu X, Xiang J. Colorectal cancer exosomes induce lymphatic network remodeling in lymph nodes. Int J Cancer. 2019;145:1648\u201359.","journal-title":"Int J Cancer"},{"key":"3443_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.gene.2018.07.018","volume":"676","author":"M Li","year":"2018","unstructured":"Li M, Lu Y, Xu Y, Wang J, Zhang C, Du Y, Wang L, Li L, Wang B, Shen J, et al. Horizontal transfer of exosomal CXCR4 promotes murine hepatocarcinoma cell migration, invasion and lymphangiogenesis. Gene. 2018;676:101\u20139.","journal-title":"Gene"},{"key":"3443_CR12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1172\/JCI130892","volume":"130","author":"C Chen","year":"2020","unstructured":"Chen C, Luo Y, He W, Zhao Y, Kong Y, Liu H, Zhong G, Li Y, Li J, Huang J, et al. Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer. J Clin Invest. 2020;130:404\u201321.","journal-title":"J Clin Invest"},{"key":"3443_CR13","doi-asserted-by":"publisher","first-page":"e147031","DOI":"10.1172\/JCI147031","volume":"131","author":"X Gong","year":"2021","unstructured":"Gong X, Tian M, Cao N, Yang P, Xu Z, Zheng S, Liao Q, Chen C, Zeng C, Jose PA, et al. Circular RNA circEsyt2 regulates vascular smooth muscle cell remodeling via splicing regulation. J Clin Invest. 2021;131:e147031.","journal-title":"J Clin Invest"},{"key":"3443_CR14","doi-asserted-by":"publisher","first-page":"e148020","DOI":"10.1172\/JCI148020","volume":"131","author":"Z Chen","year":"2021","unstructured":"Chen Z, Lu T, Huang L, Wang Z, Yan Z, Guan Y, Hu W, Fan Z, Zhu P. Circular RNA cia-MAF drives self-renewal and metastasis of liver tumor-initiating cells via transcription factor MAFF. J Clin Invest. 2021;131:e148020.","journal-title":"J Clin Invest"},{"key":"3443_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41419-022-04913-7","volume":"13","author":"T He","year":"2022","unstructured":"He T, Tao W, Zhang LL, Wang BY, Li K, Lu HM, Tang GJ, He YD, Li LY. CircSCAF8 promotes growth and metastasis of prostate cancer through the circSCAF8-miR-140-3p\/miR-335-LIF pathway. Cell Death Dis. 2022;13:517.","journal-title":"Cell Death Dis"},{"key":"3443_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.canlet.2019.12.014","volume":"472","author":"H Xu","year":"2020","unstructured":"Xu H, Sun Y, You B, Huang CP, Ye D, Chang C. Androgen receptor reverses the oncometabolite R-2-hydroxyglutarate-induced prostate cancer cell invasion via suppressing the circRNA-51217\/miRNA-646\/TGF\u03b21\/p-Smad2\/3 signaling. Cancer Lett. 2020;472:151\u201364.","journal-title":"Cancer Lett"},{"key":"3443_CR17","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1038\/s41388-018-0602-8","volume":"38","author":"Z Yang","year":"2019","unstructured":"Yang Z, Qu CB, Zhang Y, Zhang WF, Wang DD, Gao CC, Ma L, Chen JS, Liu KL, Zheng B, et al. Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway. Oncogene. 2019;38:2516\u201332.","journal-title":"Oncogene"},{"key":"3443_CR18","doi-asserted-by":"publisher","first-page":"7060","DOI":"10.1038\/s41388-019-0947-7","volume":"38","author":"S Cao","year":"2019","unstructured":"Cao S, Ma T, Ungerleider N, Roberts C, Kobelski M, Jin L, Concha M, Wang X, Baddoo M, Nguyen HM, et al. Circular RNAs add diversity to androgen receptor isoform repertoire in castration-resistant prostate cancer. Oncogene. 2019;38:7060\u201372.","journal-title":"Oncogene"},{"key":"3443_CR19","doi-asserted-by":"publisher","first-page":"101240","DOI":"10.1016\/j.xcrm.2023.101240","volume":"4","author":"W Tao","year":"2023","unstructured":"Tao W, Wang BY, Luo L, Li Q, Meng ZA, Xia TL, Deng WM, Yang M, Zhou J, Zhang X, et al. A urine extracellular vesicle lncRNA classifier for high-grade prostate cancer and increased risk of progression: a multi-center study. Cell Rep Med. 2023;4:101240.","journal-title":"Cell Rep Med"},{"key":"3443_CR20","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1002\/hed.26441","volume":"42","author":"Y Luo","year":"2020","unstructured":"Luo Y, Ma J, Liu F, Guo J, Gui R. Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma. Head Neck. 2020;42:3702\u201311.","journal-title":"Head Neck"},{"key":"3443_CR21","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/cbin.11303","volume":"44","author":"Y Zheng","year":"2020","unstructured":"Zheng Y, Li JX, Chen CJ, Lin ZY, Liu JX, Lin FJ. Extracellular vesicle-derived circ_SLC19A1 promotes prostate cancer cell growth and invasion through the miR-497\/septin 2 pathway. Cell Biol Int. 2020;44:1037\u201345.","journal-title":"Cell Biol Int"},{"key":"3443_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12943-021-01388-6","volume":"20","author":"YD He","year":"2021","unstructured":"He YD, Tao W, He T, Wang BY, Tang XM, Zhang LM, Wu ZQ, Deng WM, Zhang LX, Shao CK, et al. A urine extracellular vesicle circRNA classifier for detection of high-grade prostate cancer in patients with prostate-specific antigen 2\u201310 ng\/mL at initial biopsy. Mol Cancer. 2021;20:96.","journal-title":"Mol Cancer"},{"key":"3443_CR23","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.devcel.2021.01.018","volume":"56","author":"L Ducoli","year":"2021","unstructured":"Ducoli L, Detmar M. Beyond PROX1: transcriptional, epigenetic, and noncoding RNA regulation of lymphatic identity and function. Dev Cell. 2021;56:406\u201326.","journal-title":"Dev Cell"},{"key":"3443_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/gutjnl-2013-306388","volume":"64","author":"L Liu","year":"2015","unstructured":"Liu L, Lin C, Liang W, Wu S, Liu A, Wu J, Zhang X, Ren P, Li M, Song L. TBL1XR1 promotes lymphangiogenesis and lymphatic metastasis in esophageal squamous cell carcinoma. Gut. 2015;64:26\u201336.","journal-title":"Gut"},{"key":"3443_CR25","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1038\/s41467-018-06152-x","volume":"9","author":"C Chen","year":"2018","unstructured":"Chen C, He W, Huang J, Wang B, Li H, Cai Q, Su F, Bi J, Liu H, Zhang B, et al. LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment. Nat Commun. 2018;9:3826.","journal-title":"Nat Commun"},{"key":"3443_CR26","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1172\/JCI34780","volume":"118","author":"G Narla","year":"2008","unstructured":"Narla G, DiFeo A, Fernandez Y, Dhanasekaran S, Huang F, Sangodkar J, Hod E, Leake D, Friedman SL, Hall SJ, et al. KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis. J Clin Invest. 2008;118:2711\u201321.","journal-title":"J Clin Invest"},{"key":"3443_CR27","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1038\/ncomms3980","volume":"4","author":"C Villarroya-Beltri","year":"2013","unstructured":"Villarroya-Beltri C, Guti\u00e9rrez-V\u00e1zquez C, S\u00e1nchez-Cabo F, P\u00e9rez-Hern\u00e1ndez D, V\u00e1zquez J, Martin-Cofreces N, Martinez-Herrera DJ, Pascual-Montano A, Mittelbrunn M, S\u00e1nchez-Madrid F. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 2013;4:2980.","journal-title":"Nat Commun"},{"key":"3443_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13059-018-1604-0","volume":"20","author":"X Qin","year":"2019","unstructured":"Qin X, Guo H, Wang X, Zhu X, Yan M, Wang X, Xu Q, Shi J, Lu E, Chen W, Zhang J. Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5. Genome Biol. 2019;20:12.","journal-title":"Genome Biol"},{"key":"3443_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.canlet.2020.03.017","volume":"479","author":"A Kumar","year":"2020","unstructured":"Kumar A, Deep G. Hypoxia in tumor microenvironment regulates exosome biogenesis: Molecular mechanisms and translational opportunities. Cancer Lett. 2020;479:23\u201330.","journal-title":"Cancer Lett"},{"key":"3443_CR30","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/emboj\/20.4.672","volume":"20","author":"SJ Mandriota","year":"2001","unstructured":"Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG, et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. Embo J. 2001;20:672\u201382.","journal-title":"Embo J"},{"key":"3443_CR31","first-page":"1786","volume":"61","author":"T Karpanen","year":"2001","unstructured":"Karpanen T, Egeblad M, Karkkainen MJ, Kubo H, Yl\u00e4-Herttuala S, J\u00e4\u00e4ttel\u00e4 M, Alitalo K. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 2001;61:1786\u201390.","journal-title":"Cancer Res"},{"key":"3443_CR32","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41392-023-01576-4","volume":"8","author":"H Ji","year":"2023","unstructured":"Ji H, Hu C, Yang X, Liu Y, Ji G, Ge S, Wang X, Wang M. Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions. Signal Transduct Target Ther. 2023;8:367.","journal-title":"Signal Transduct Target Ther"},{"key":"3443_CR33","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1242\/dev.106591","volume":"141","author":"JW Astin","year":"2014","unstructured":"Astin JW, Haggerty MJ, Okuda KS, Le Guen L, Misa JP, Tromp A, Hogan BM, Crosier KE, Crosier PS. Vegfd can compensate for loss of Vegfc in zebrafish facial lymphatic sprouting. Development. 2014;141:2680\u201390.","journal-title":"Development"},{"key":"3443_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccr.2011.12.026","volume":"21","author":"T Karnezis","year":"2012","unstructured":"Karnezis T, Shayan R, Caesar C, Roufail S, Harris NC, Ardipradja K, Zhang YF, Williams SP, Farnsworth RH, Chai MG, et al. VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell. 2012;21:181\u201395.","journal-title":"Cancer Cell"},{"key":"3443_CR35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1161\/CIRCRESAHA.118.313707","volume":"124","author":"H Cho","year":"2019","unstructured":"Cho H, Kim J, Ahn JH, Hong YK, M\u00e4kinen T, Lim DS, Koh GY. YAP and TAZ negatively regulate Prox1 during developmental and pathologic lymphangiogenesis. Circ Res. 2019;124:225\u201342.","journal-title":"Circ Res"},{"key":"3443_CR36","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/hep.31493","volume":"73","author":"Y Xu","year":"2021","unstructured":"Xu Y, Leng K, Yao Y, Kang P, Liao G, Han Y, Shi G, Ji D, Huang P, Zheng W, et al. A Circular RNA, Cholangiocarcinoma-Associated Circular RNA 1, Contributes to Cholangiocarcinoma Progression, Induces Angiogenesis, and Disrupts Vascular Endothelial Barriers. Hepatology. 2021;73:1419\u201335.","journal-title":"Hepatology"},{"key":"3443_CR37","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1093\/nar\/gkab252","volume":"49","author":"C Xu","year":"2021","unstructured":"Xu C, Tsai YH, Galbo PM, Gong W, Storey AJ, Xu Y, Byrum SD, Xu L, Whang YE, Parker JS, et al. Cistrome analysis of YY1 uncovers a regulatory axis of YY1:BRD2\/4-PFKP during tumorigenesis of advanced prostate cancer. Nucleic Acids Res. 2021;49:4971\u201388.","journal-title":"Nucleic Acids Res"},{"key":"3443_CR38","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1016\/j.molcel.2021.03.034","volume":"81","author":"K Shinoda","year":"2021","unstructured":"Shinoda K, Zong D, Callen E, Wu W, Dumitrache LC, Belinky F, Chari R, Wong N, Ishikawa M, Stanlie A, et al. The dystonia gene THAP1 controls DNA double-strand break repair choice. Mol Cell. 2021;81:2611-2624.e2610.","journal-title":"Mol Cell"},{"key":"3443_CR39","doi-asserted-by":"publisher","first-page":"e157644","DOI":"10.1172\/JCI157644","volume":"132","author":"Y Luo","year":"2022","unstructured":"Luo Y, Li Z, Kong Y, He W, Zheng H, An M, Lin Y, Zhang D, Yang J, Zhao Y, et al. KRAS mutant-driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer. J Clin Invest. 2022;132:e157644.","journal-title":"J Clin Invest"},{"key":"3443_CR40","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/emboj\/21.7.1505","volume":"21","author":"JT Wigle","year":"2002","unstructured":"Wigle JT, Harvey N, Detmar M, Lagutina I, Grosveld G, Gunn MD, Jackson DG, Oliver G. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. Embo J. 2002;21:1505\u201313.","journal-title":"Embo J"},{"key":"3443_CR41","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1182\/blood-2008-03-145789","volume":"113","author":"S Lee","year":"2009","unstructured":"Lee S, Kang J, Yoo J, Ganesan SK, Cook SC, Aguilar B, Ramu S, Lee J, Hong YK. Prox1 physically and functionally interacts with COUP-TFII to specify lymphatic endothelial cell fate. Blood. 2009;113:1856\u20139.","journal-title":"Blood"},{"key":"3443_CR42","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1101\/gad.1727208","volume":"22","author":"NC Johnson","year":"2008","unstructured":"Johnson NC, Dillard ME, Baluk P, McDonald DM, Harvey NL, Frase SL, Oliver G. Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity. Genes Dev. 2008;22:3282\u201391.","journal-title":"Genes Dev"},{"key":"3443_CR43","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1093\/emboj\/cdf470","volume":"21","author":"TV Petrova","year":"2002","unstructured":"Petrova TV, M\u00e4kinen T, M\u00e4kel\u00e4 TP, Saarela J, Virtanen I, Ferrell RE, Finegold DN, Kerjaschki D, Yl\u00e4-Herttuala S, Alitalo K. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. Embo J. 2002;21:4593\u20139.","journal-title":"Embo J"},{"key":"3443_CR44","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cell.2019.01.025","volume":"176","author":"S Chen","year":"2019","unstructured":"Chen S, Huang V, Xu X, Livingstone J, Soares F, Jeon J, Zeng Y, Hua JT, Petricca J, Guo H, et al. Widespread and functional RNA circularization in localized prostate cancer. Cell. 2019;176:831-843.e822.","journal-title":"Cell"},{"key":"3443_CR45","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1158\/0008-5472.CAN-18-1559","volume":"79","author":"F Yang","year":"2019","unstructured":"Yang F, Fang E, Mei H, Chen Y, Li H, Li D, Song H, Wang J, Hong M, Xiao W, et al. Cis-acting circ-CTNNB1 promotes \u03b2-catenin signaling and cancer progression via DDX3-mediated transactivation of YY1. Cancer Res. 2019;79:557\u201371.","journal-title":"Cancer Res"},{"key":"3443_CR46","doi-asserted-by":"publisher","first-page":"12019","DOI":"10.1093\/nar\/gkac230","volume":"50","author":"X Dong","year":"2022","unstructured":"Dong X, Guo R, Ji T, Zhang J, Xu J, Li Y, Sheng Y, Wang Y, Fang K, Wen Y, et al. YY1 safeguard multidimensional epigenetic landscape associated with extended pluripotency. Nucleic Acids Res. 2022;50:12019\u201338.","journal-title":"Nucleic Acids Res"},{"key":"3443_CR47","doi-asserted-by":"publisher","first-page":"961","DOI":"10.2337\/db21-0695","volume":"71","author":"D Liu","year":"2022","unstructured":"Liu D, Yang KY, Chan VW, Ye W, Chong CCN, Wang CC, Wang H, Zhou B, Cheng KKY, Lui KO. YY1 regulates glucose homeostasis through controlling insulin transcription in pancreatic \u03b2-cells. Diabetes. 2022;71:961\u201377.","journal-title":"Diabetes"},{"key":"3443_CR48","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/s41467-024-45386-w","volume":"15","author":"T Liu","year":"2024","unstructured":"Liu T, Zhu Q, Kai Y, Bingham T, Wang S, Cha HJ, Mehta S, Schlaeger TM, Yuan GC, Orkin SH. Matrin3 mediates differentiation through stabilizing chromatin loop-domain interactions and YY1 mediated enhancer-promoter interactions. Nat Commun. 2024;15:1274.","journal-title":"Nat Commun"},{"key":"3443_CR49","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29:341\u20135.","journal-title":"Nat Biotechnol"},{"key":"3443_CR50","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41392-021-00779-x","volume":"6","author":"C Li","year":"2021","unstructured":"Li C, Ni YQ, Xu H, Xiang QY, Zhao Y, Zhan JK, He JY, Li S, Liu YS. Roles and mechanisms of exosomal non-coding RNAs in human health and diseases. Signal Transduct Target Ther. 2021;6:383.","journal-title":"Signal Transduct Target Ther"},{"key":"3443_CR51","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.canlet.2021.02.011","volume":"505","author":"R Munagala","year":"2021","unstructured":"Munagala R, Aqil F, Jeyabalan J, Kandimalla R, Wallen M, Tyagi N, Wilcher S, Yan J, Schultz DJ, Spencer W, Gupta RC. Exosome-mediated delivery of RNA and DNA for gene therapy. Cancer Lett. 2021;505:58\u201372.","journal-title":"Cancer Lett"},{"key":"3443_CR52","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jconrel.2019.11.009","volume":"317","author":"G Kim","year":"2020","unstructured":"Kim G, Kim M, Lee Y, Byun JW, Hwang DW, Lee M. Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes. J Control Release. 2020;317:273\u201381.","journal-title":"J Control Release"},{"key":"3443_CR53","doi-asserted-by":"publisher","first-page":"e2311071","DOI":"10.1002\/smll.202311071","volume":"20","author":"C Hu","year":"2024","unstructured":"Hu C, Chen Q, Wu T, Du X, Dong Y, Peng Z, Xue W, Sunkara V, Cho YK, Dong L. The role of extracellular vesicles in the treatment of prostate cancer. Small. 2024;20:e2311071.","journal-title":"Small"},{"key":"3443_CR54","doi-asserted-by":"publisher","first-page":"101646","DOI":"10.1016\/j.mtbio.2025.101646","volume":"32","author":"LY Li","year":"2025","unstructured":"Li LY, Liang SY, Cai MP, Ge JC, Tan HS, Wang CB, Xu B. Engineered extracellular vesicles as imaging biomarkers and therapeutic applications for urological diseases. Mater Today Bio. 2025;32:101646.","journal-title":"Mater Today Bio"},{"key":"3443_CR55","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/s41596-020-00466-1","volume":"16","author":"R Crescitelli","year":"2021","unstructured":"Crescitelli R, L\u00e4sser C, L\u00f6tvall J. Isolation and characterization of extracellular vesicle subpopulations from tissues. Nat Protoc. 2021;16:1548\u201380.","journal-title":"Nat Protoc"},{"key":"3443_CR56","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1038\/onc.2010.213","volume":"29","author":"X Gao","year":"2010","unstructured":"Gao X, Pang J, Li LY, Liu WP, Di JM, Sun QP, Fang YQ, Liu XP, Pu XY, He D, et al. Expression profiling identifies new function of collapsin response mediator protein 4 as a metastasis-suppressor in prostate cancer. Oncogene. 2010;29:4555\u201366.","journal-title":"Oncogene"},{"key":"3443_CR57","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1158\/1078-0432.CCR-19-2297","volume":"26","author":"MA Piano","year":"2020","unstructured":"Piano MA, Brunello A, Cappellesso R, Del Bianco P, Mattiolo A, Fritegotto C, Montini B, Zamuner C, Del Fiore P, Rastrelli M, et al. Periostin and epithelial-mesenchymal transition score as novel prognostic markers for leiomyosarcoma, myxofibrosarcoma, and undifferentiated pleomorphic sarcoma. Clin Cancer Res. 2020;26:2921\u201331.","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03443-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03443-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03443-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T09:03:57Z","timestamp":1751533437000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03443-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3443"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03443-2","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Shanghai Ninth People's Hospital.Written informed consent to participate wasobtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"188"}}